Logo image of MKUL

MOLEKULE GROUP INC (MKUL) Stock Fundamental Analysis

NASDAQ:MKUL - Nasdaq - US0077441055 - Common Stock - Currency: USD

0.0541  -0.04 (-39.89%)

After market: 0.0519 0 (-4.07%)

Fundamental Rating

1

Overall MKUL gets a fundamental rating of 1 out of 10. We evaluated MKUL against 41 industry peers in the Building Products industry. Both the profitability and financial health of MKUL have multiple concerns. MKUL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MKUL had negative earnings in the past year.
MKUL had a negative operating cash flow in the past year.
MKUL Yearly Net Income VS EBIT VS OCF VS FCFMKUL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

The Return On Assets of MKUL (-26.57%) is worse than 90.91% of its industry peers.
MKUL has a Return On Equity of -81.87%. This is amonst the worse of the industry: MKUL underperforms 86.36% of its industry peers.
Industry RankSector Rank
ROA -26.57%
ROE -81.87%
ROIC N/A
ROA(3y)-52.87%
ROA(5y)N/A
ROE(3y)-66.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MKUL Yearly ROA, ROE, ROICMKUL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 50 -50 -100

1.3 Margins

Looking at the Gross Margin, with a value of 37.90%, MKUL belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for MKUL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MKUL Yearly Profit, Operating, Gross MarginsMKUL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -2K -4K -6K

More info and screens

2

2. Health

2.1 Basic Checks

MKUL does not have a ROIC to compare to the WACC, probably because it is not profitable.
MKUL has more shares outstanding than it did 1 year ago.
MKUL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MKUL Yearly Shares OutstandingMKUL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 5M 10M 15M
MKUL Yearly Total Debt VS Total AssetsMKUL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -0.92, we must say that MKUL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.92, MKUL is doing worse than 93.18% of the companies in the same industry.
MKUL has a Debt/Equity ratio of 0.84. This is a neutral value indicating MKUL is somewhat dependend on debt financing.
MKUL has a Debt to Equity ratio (0.84) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z -0.92
ROIC/WACCN/A
WACC10.48%
MKUL Yearly LT Debt VS Equity VS FCFMKUL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 2.27 indicates that MKUL has no problem at all paying its short term obligations.
MKUL's Current ratio of 2.27 is in line compared to the rest of the industry. MKUL outperforms 56.82% of its industry peers.
MKUL has a Quick Ratio of 2.27. This is a bad value and indicates that MKUL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.57, MKUL is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 0.57
MKUL Yearly Current Assets VS Current LiabilitesMKUL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

MKUL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.24%, which is quite impressive.
MKUL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.90%.
EPS 1Y (TTM)43.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.41%
Revenue 1Y (TTM)-62.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18814.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-274%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14957.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MKUL Yearly Revenue VS EstimatesMKUL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M 40M 50M
MKUL Yearly EPS VS EstimatesMKUL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MKUL. In the last year negative earnings were reported.
Also next year MKUL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MKUL Price Earnings VS Forward Price EarningsMKUL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MKUL Per share dataMKUL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MKUL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOLEKULE GROUP INC

NASDAQ:MKUL (10/12/2023, 8:00:01 PM)

After market: 0.0519 0 (-4.07%)

0.0541

-0.04 (-39.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-14 2023-08-14/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners22.18%
Ins Owner Change0%
Market Cap1.87M
Analysts43.33
Price Target7.14 (13097.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-210.46%
Min EPS beat(2)-210.46%
Max EPS beat(2)-210.46%
EPS beat(4)1
Avg EPS beat(4)68.41%
Min EPS beat(4)-210.46%
Max EPS beat(4)511.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)8.17%
Min Revenue beat(2)8.17%
Max Revenue beat(2)8.17%
Revenue beat(4)1
Avg Revenue beat(4)-47.93%
Min Revenue beat(4)-96.08%
Max Revenue beat(4)8.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)99900%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-1.8
Fwd EYN/A
FCF(TTM)-1.01
FCFYN/A
OCF(TTM)-0.97
OCFYN/A
SpS0.63
BVpS1.17
TBVpS-0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.57%
ROE -81.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.9%
FCFM N/A
ROA(3y)-52.87%
ROA(5y)N/A
ROE(3y)-66.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 103.42%
Cap/Sales 5.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 0.57
Altman-Z -0.92
F-Score1
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.41%
EPS Next Y-274%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-62.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18814.29%
Revenue Next Year14957.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-108.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-283.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-391.39%
OCF growth 3YN/A
OCF growth 5YN/A